Clinical-Microbiomics A/S: Financial statements 2021
CVR: 37230634
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Clinical-Microbiomics A/S (CVR 37230634) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 16,768,941 and a net result of DKK -1,722,969 compared with DKK 816,247 the year before. That is a decrease of 1.5% compared with the year before. Equity in the 2021 report amounted to DKK 2,825,608. The solvency ratio was 10%. The company had 26 employees in the financial year.
- Gross Profit
- DKK 16,768,941
- Profit/Loss
- DKK -1,722,969
- Equity
- DKK 2,825,608
- Total Assets
- DKK 28,266,082
- Employees
- 26
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 16.8M | -1.7M | 2.8M | 26 |
| 2020 | - | 17M | 816K | -3.3M | 19 |
| 2019 | - | 13.2M | 107K | -4.1M | 16 |
| 2018 | - | 8.5M | -483K | -4.3M | 12 |
| 2017 | - | 1.4M | -4.4M | -3.8M | 9 |
Official annual report
Find more companies like Clinical-Microbiomics A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of October 1, 2021, Anders Christian Neto de Sousa Grøn is registered as adm. dir. of Clinical-Microbiomics A/S.
As of September 30, 2021, Martin Andreas Santini has stepped down as adm. dir. of Clinical-Microbiomics A/S.
As of June 28, 2021, Morten Asser Karsdal has left the board of directors of Clinical-Microbiomics A/S.
As of June 8, 2021, Ole Skov has left the board of directors of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S has published its annual report for 2020. Gross profit came to DKK 17,023,992, and the net result was DKK 816,247.
As of January 28, 2021, Ole Skov has joined the board of directors of Clinical-Microbiomics A/S.
As of January 28, 2021, Thomas Alsbjerg has joined the board of directors of Clinical-Microbiomics A/S.
As of January 28, 2021, Dennis Landbo Nielsen has left the board of directors of Clinical-Microbiomics A/S.
About Clinical-Microbiomics A/S
Clinical-Microbiomics A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Clinical-Microbiomics ApS. The management consists of Anders Christian Neto de Sousa Grøn. The board consists of Manoj Nirmal Dadlani (chair), Bruce Harvey Grant, Caroline Popper and Isabelle Valerie de Cremoux. The company's owners include MANJIN ApS, VENDLER ApS and Health For Life Capital II Prima S.C.A. RAIF. The company has 32 employees (2026). In 2025, the company reported a gross profit of EUR 2,831,000 and a net result of EUR -2,586,000 compared with EUR -4,328,000 the year before. Equity in the 2025 report amounted to EUR 85,447,000.